New nanoparticles can perform gene editing in the lungs, MIT News

A new type of nanoparticle can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Researchers hope to use them to develop new treatments for cystic fibrosis and other lung diseases.

Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing

Gene Editing: Exploring the Boundaries of Innovation and Ethics by Joshua T. Berglan, by Joshua T Berglan 'The World's Mayor', Feb, 2024

Advancements in Lipid Nanoparticles for Targeted Gene Therapy in the Lungs

New Inhalable Nanoparticles Perform Gene Editing Inside the Lungs

New nanoparticles weaken tumor-cell defenses, then strike with chemotherapy drug

Genetic Engineering 2.0: An On-Off Switch for Gene Editing

New Nanoparticles Carrying mRNA Can Perform In-Lung Gene Editing

Nanoparticles target lung disease

Nanoparticles may correct genetic defects in cystic fibrosis lungs

New nanoparticles deliver gene-editing tech directly into the lungs

Novel nanoparticles deliver CRISPR gene editing tools into the cell with much higher efficiency

CRISPR Takes a Giant Leap Forward in Live Animal Gene Editing